Member Info for Early_Bird

Been buying in here recently. Placing overhang looks to be finally drying up with 3 x placing volume traded since. Price action is looking like a breakout is nearing and charts pointing 4.4p area. Break that and its blue sky. Like that its fully funded for 2017, has no debt and potentially huge upside should a farm in or finance for a drill be announced. Algy Cluff one of the original pioneers of the North Sea so great to see him back trying to do what he does best, now aided by modern technology. Speculative but with low risk and great technicals. GLA

That fact they had £1.2m in September last year isnt my opinion, its FACT. Do you bother to read RNS releases?? I chose to leave that twitter group because about 6 months ago, it was full of just you posting misinformation, or implying huge things were coming when clearly you didnt have a scooby. Im invested here too, and noone knows anything until we get th next update. Wild speculation implying you know more than others or pulling the wool over investors eyes and twisting facts by posting the accounts that are 18 months old and trying to pass it off as current cash balance isnt how to play cricket. If you provided some transparency in your posts then youd get my respect but you dont. From my correspondence with Adrian things are progressing (as always) and we await the next update. Until then let chose to base things on facts not fiction.

Shukan,you are posting information that is 18 months out of date. proving how brilliant you are yet again failing to read black and white and twisting simple facts. The most recent accounts: "Highlights Successfully admitted to trading on the Main Market of the London Stock Exchange on 9th November 2015 Raised £1.5m cash (gross) through the issue of 64.9m new ordinary shares Cash balance at 30 June 2016 was £1.2m Cash balance at the date of this report is £1.2m" so lets bet very clear is £1.2m from the most recent date given which was 5 months ago.

Good to see this gaiing some traction again. Still holding my IPO shares in the bottom drawer ready for things to kick off here. Solid cash, management taking next to no salary and skin in game with great record of achieving deals with significant SH returns, such as HNR (10 bagged from bottom to top)

background buyer

up to 2.5% here. Like the potential.

*£1.2m quid to invest All will be forgiven here with regards to their 12month+ lock in here IF they source a cracking deal. This is a new year at least, lets hope this BOD can salvage their repuations.

*2017

Certainly one of my top 3 picks for 2018, fully funded and about to go in to P3 trials for EB. This is significant given what happened to the only other competitor once they started their P3 trials... Also producing revenues and has EU approved drug, has the founder of the worlds largest orphan drug company, Shire, as chairman (with AMYT looking to be shire MK2) all for £40m MC... far too low.

to begin here imminently. Exciting times. Should be finally punching through blue sky on the chart in Q1

in the clouds or feet on the ground.

Shukan words fail me with you chap. Only person I think ive ever blocked on twitter. You lead people down a garden path, pretend you know inside information and are above everyone else. You are an A1 BSer. 0% of what you have intimated has come true so id say theres about 0% chance your source of your inside information is legitimate sadly. Lets leave it at that.

Well done all here. Not invested but was once upon a time ago. Rewards well deserved

For me as long as they aint spending the cash im relaxed. If it relists now it would be valued at cash no more (so 1.5p) but at least its something that I could invest and bag elsewhere to get the losses back. Will be watching the next set of results carefully assuming thats the next most likely piece of news we will be getting here.

It all hinges on how much cash they are burning. If the next set of results showing cash below £1m then we need to start to take action here. Each day that passes the cash drip drip drips away. In my mind this shouldnt be suspended, it should have had suspension lifted once lime fell through - same as SEN. The only reason it wasnt taken out of suspension is because they claimed to be reviewing two other opportunities.... yet another 2 1/2 months pass..... and nada. Theres only so much of being led down the garden path we should tolerate here.

*Patients

Still on track to commence next month. Only other competitor got bought out for $842m as soon as they commenced their P3 trials last year (which have now been delayed as well). Amyts Episalvan has a huge positive over this competitor in that it doesnt requre daily application. When it takes 3-4 hours of patience to change their dressings Amyts Epsilvan will only req application every 2-3 days on standard dressing changes. Im so glad I have a nice wad of these + warrants.

Loan secured meaning no further dilution and now BOD show their commercial capabilities with securing this latest contract. Ignore the experience and capabilities of this BOD at your own cost/ignorance Buy, bottom drawer. Wait till buyout for multiples. That is all.

being proved wrong here. Great to watch. They know who they are.

No risk of dilution. Only another 100% and will be in profit from my IPO shares! lol